Inovio Pharmaceuticals, Inc.
INO
$2.04
$0.094.62%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 47.55M | 68.36M | 94.11M | 84.80M | 110.42M |
| Total Receivables | 840.30K | 1.31M | 1.20M | 1.86M | 1.77M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 4.31M | 2.22M | 2.52M | 4.62M | 5.37M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 52.70M | 71.89M | 97.83M | 91.28M | 117.56M |
|
|
|||||
| Total Current Assets | 52.70M | 71.89M | 97.83M | 91.28M | 117.56M |
| Net Property, Plant & Equipment | 10.45M | 11.09M | 11.77M | 12.56M | 13.33M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.01M | 1.98M | 1.98M | 566.40K | 585.90K |
| Total Assets | 68.24M | 87.27M | 113.20M | 107.06M | 133.80M |
|
|
|||||
| Total Accounts Payable | 5.48M | 5.52M | 6.44M | 5.39M | 6.41M |
| Total Accrued Expenses | 12.15M | 9.68M | 13.13M | 15.69M | 17.65M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.66M | 2.58M | 2.50M | 2.43M | 2.32M |
| Total Finance Division Other Current Liabilities | 11.42M | 9.54M | 13.26M | -- | 21.90K |
| Total Other Current Liabilities | 11.42M | 9.54M | 13.26M | -- | 21.90K |
| Total Current Liabilities | 31.71M | 27.33M | 35.33M | 23.50M | 26.40M |
|
|
|||||
| Total Current Liabilities | 31.71M | 27.33M | 35.33M | 23.50M | 26.40M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 8.00M | 8.70M | 9.37M | 10.02M | 10.66M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 39.71M | 36.02M | 44.69M | 33.52M | 37.06M |
|
|
|||||
| Common Stock & APIC | 1.80B | 1.80B | 1.80B | 1.79B | 1.78B |
| Retained Earnings | -1.77B | -1.75B | -1.73B | -1.71B | -1.69B |
| Treasury Stock & Other | -661.70K | -661.30K | -675.70K | -623.50K | -689.50K |
| Total Common Equity | 28.53M | 51.25M | 68.50M | 73.54M | 96.74M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 28.53M | 51.25M | 68.50M | 73.54M | 96.74M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 28.53M | 51.25M | 68.50M | 73.54M | 96.74M |
|
|
|||||